New Tech Aims to Tackle ‘Disseminated Intravascular Coagulation’ Blood Disorder
[Editor s note from Tracey du Laney, Ph.D., the North Carolina Biotechnology Center’s senior director of Science and Technology Development, who oversees this grant
: This line of research exemplifies what a Flash Grant is all about. The nanosphere technology that Dr. Brown’s team is developing addresses a large patient population with unmet needs in a new way. It could lead to new therapeutics to treat disseminated intravascular coagulation (DIC). DIC results not just from sepsis and cancer, but also has emerged as a life-threatening condition with COVID-19. Using new technologies to treat new threats and disrupt current methods of treating patients is a great example of a Flash Grant.]
Researchers have developed a new tool for addressing disseminated intravascular coagulation (DIC) - a blood disorder that proves fatal in many patients..
RALEIGH - Researchers have developed a new tool for addressing disseminated intravascular coagulation (DIC) – a blood disorder that proves fatal in many